Mapping active myelination with BCAS1
Neuronal axon demyelination causes motor and cognitive impairments in multiple sclerosis (MS) and other demyelinating disorders. Although remyelinating strategies have been proposed, the lack of markers to detect areas of active myelination hampers the development of effective therapies. Fard et al. show that myelinating oligodendrocytes constitute a unique population expressing breast carcinoma amplified sequence 1 (BCAS1) in rodent and human brain tissue. In brain samples from deceased MS patients, BCAS1+ cells are present around lesions, suggesting that remyelination might occur during MS and that BCAS1 expression could be used to track responses to remyelinating compounds for treating demyelinating disorders.
- Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.
